乳腺癌篩查中的全球計算機輔助診斷 (CAD):增長機會
市場調查報告書
商品編碼
1062776

乳腺癌篩查中的全球計算機輔助診斷 (CAD):增長機會

Growth Opportunities for Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening

出版日期: | 出版商: Frost & Sullivan | 英文 101 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球用於乳腺癌篩查的計算機輔助診斷(CAD)市場將在 2021 年達到 1.18 億美元,並以 7.0% 的複合年增長率增長,到 2026 年達到 1.657 億美元。

因為它被用作乳腺癌篩查的主要工具,所以乳腺 X 線攝影和超聲 CAD 部分預計將顯示出最高的增長率。

本報告調查和分析用於乳腺癌篩查的全球計算機輔助診斷 (CAD) 市場,並提供有關戰略要求、增長機會分析和區域增長機會分析的信息。

目錄

戰略要求

  • 為什麼增長變得越來越困難?
  • 戰略要務 8 (TM)
  • 全球計算機輔助診斷 (CAD) 三大戰略要求對乳腺癌篩查市場的影響
  • 增長機會推動增長管道引擎 (TM)

增長機會分析

  • 主要亮點
  • 乳腺癌篩查中的 CAD:分析範圍
  • 市場概況
  • 市場細分:按技術
  • 用於乳腺癌篩查的 CAD:主要區域競爭對手
  • 乳腺癌篩查中的 CAD:關鍵生長指標
  • 乳腺癌篩查中的 CAD:生長促進劑
  • 乳腺癌篩查中的 CAD:生長抑製劑
  • 假設是一種預測研究方法
  • 收入預測
  • 全球盈利預測分析
  • 收入預測:按細分市場
  • 乳腺 X 線攝影 CAD:收入預測
  • 乳腺攝影 CAD:利潤預測分析
  • 超聲波 CAD:收入預測
  • 超聲波 CAD:收入預測分析
  • PET/CT-CAD:收入預測
  • PET/CT-CAD:收入預測分析
  • MRI-CAD:收入預測
  • MRI-CAD:收入預測分析
  • 收入預測:按地區
  • 收入預測分析:按地區
  • 乳腺癌篩查加元價格趨勢預測:按產品分類
  • 價格趨勢和預測分析
  • 競爭環境
  • 乳腺癌篩查中的 CAD 採用曲線:按產品類型
  • 主要競爭對手-Hologic
  • 主要競爭對手-iCAD
  • 收入分成
  • 收入份額分析
  • 商業模式概覽-乳腺癌篩查中的CAD
  • 臨床最終用戶觀點
  • 乳腺癌篩查市場中的 CAD:考慮工作流程和無縫集成的因素

增長機會分析:北美

  • 北美乳腺癌篩查市場的 CAD:主要增長指標
  • 北美乳腺癌篩查市場中的 CAD:市場動態
  • 北美盈利預測
  • 北美分部回報率
  • 北美分部分析的收入預測
  • 競爭環境:北美
  • 競爭環境分析:北美

增長機會分析:歐洲

  • 歐洲乳腺癌篩查市場的 CAD:主要增長指標
  • CAD 在歐洲乳腺癌篩查市場:市場動態
  • 歐洲盈利預測
  • 按細分市場劃分的歐洲回報率
  • 歐洲分部分析的收入預測
  • 競爭環境:歐洲
  • 競爭環境分析:歐洲

增長機會分析:亞太地區

  • 亞太地區乳腺癌篩查市場的 CAD:主要增長指標
  • 亞太地區乳腺癌篩查市場的 CAD:市場動態
  • 亞太地區收入預測
  • 亞太地區按細分市場劃分的回報率
  • 按分部分析的亞太地區收入預測
  • 競爭環境:亞太地區
  • 競爭環境分析:亞太地區

增長機會分析:其他地區

  • 其他地區乳腺癌篩查市場的 CAD:主要增長指標
  • CAD 在其他地區的乳腺癌篩查市場:市場動態
  • 其他地區的盈利預測
  • 其他地區的細分回報率
  • 其他地區按細分分析得出的收入預測
  • 競爭環境:其他地區
  • 競爭環境分析:其他地區

增長機會宇宙

  • 增長機會概覽
  • 增長機會 1-使用移動乳房 X 光檢查和移動超聲篩查乳腺癌的機會
  • 增長機會 2-AI 與 DL 相結合,以支持更好的乳腺癌篩查臨床結果
  • 增長機會 3 - 使用 CAD 分類 (CADt) 來增加人為錯誤並提高乳房圖像的效率
  • 增長機會4-與OEM合作提供乳房篩查系統以獲得更廣泛的客戶群
  • 增長機會 5 - 亞太地區增加使用 CAD 以提高臨床採用率

下一步

簡介目錄
Product Code: PC50-50

Artificial Intelligence and Deep Learning Support Better Clinical Outcomes and Fuel Growth Pipeline

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due to their use as a primary tool for breast cancer detection. These segments are followed by MRI-CAD, which is mainly used as an adjunct to both mammography and ultrasound in breast imaging.

Analysis of the competitive landscape indicates that the top companies accounted for a combined 95% of the total CAD in breast cancer screening market for 2021. Offering AI-enabled CAD solutions is a growth area observed in the market. Given the market dynamics, trends, and competitive nature, it is important for industry stakeholders to have an overall perspective of the technology segments and workflow. This report offers insightful analysis of CAD in breast cancer screening in the form of a global forecast, regional and technological forecasts and analyses, benchmarking of top competitors, and key growth opportunities for industry participants.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening Market
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Main Highlights
  • CAD in Breast Cancer Screening Scope of Analysis
  • Market Overview
  • Market Segmentation by Technology
  • Key Competitors by Region for CAD in Breast Cancer Screening
  • Key Growth Metrics for CAD in Breast Cancer Screening
  • Growth Drivers for CAD in Breast Cancer Screening
  • Growth Restraints for CAD in Breast Cancer Screening
  • Forecast Methodology and Assumptions
  • Revenue Forecast
  • Global Revenue Forecast Analysis
  • Revenue Forecast by Segment
  • Mammo-CAD Revenue Forecast
  • Mammo-CAD-Revenue Forecast Analysis
  • Ultrasound-CAD Revenue Forecast
  • Ultrasound CAD-Revenue Forecast Analysis
  • PET/CT-CAD Revenue Forecast
  • PET/CT-CAD-Revenue Forecast Analysis
  • MRI-CAD Revenue Forecast
  • MRI-CAD-Revenue Forecast Analysis
  • Revenue Forecast by Region
  • Revenue Forecast Analysis by Region
  • Pricing Trends Forecast by Product, CAD in Breast Cancer Screening
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • Adoption Curve of CAD in Breast Cancer Screening by Product Type
  • Top Competitor-Hologic
  • Top Competitor-iCAD
  • Revenue Share
  • Revenue Share Analysis
  • Business Model Overview-CAD in Breast Cancer Screening
  • Clinical End-user Perspective
  • Factors to Consider for Seamless Integration with Workflow-CAD in Breast Cancer Screening Market

Growth Opportunity Analysis, North America

  • Key Growth Metrics for CAD in Breast Cancer Screening Market, North America
  • CAD in Breast Cancer Screening Market Dynamics, North America
  • Revenue Forecast, North America
  • Percent Revenue by Segment, North America
  • Revenue Forecast by Segment Analysis, North America
  • Revenue Forecast by Segment Discussion, North America (continued)
  • Competitive Environment, North America
  • Competitive Environment Analysis, North America

Growth Opportunity Analysis, Europe

  • Key Growth Metrics for CAD in Breast Cancer Screening Market, Europe
  • CAD in Breast Cancer Screening Market Dynamics, Europe
  • Revenue Forecast, Europe
  • Percent Revenue by Segment, Europe
  • Revenue Forecast by Segment Analysis, Europe
  • Revenue Forecast by Segment Analysis, Europe (continued)
  • Competitive Environment, Europe
  • Competitive Environment Analysis, Europe

Growth Opportunity Analysis, APAC

  • Key Growth Metrics for CAD in Breast Cancer Screening Market, APAC
  • CAD in Breast Cancer Screening Market Dynamics, APAC
  • Revenue Forecast, APAC
  • Percent Revenue by Segment, APAC
  • Revenue Forecast by Segment Analysis, APAC
  • Revenue Forecast by Segment Analysis, APAC (continued)
  • Competitive Environment, APAC
  • Competitive Environment Analysis, APAC

Growth Opportunity Analysis, ROW

  • Key Growth Metrics for CAD in Breast Cancer Screening Market, ROW
  • CAD in Breast Cancer Screening Market Dynamics, ROW
  • Revenue Forecast, ROW
  • Percent Revenue by Segment, ROW
  • Revenue Forecast by Segment Analysis, ROW
  • Revenue Forecast by Segment Analysis, ROW (continued)
  • Competitive Environment, ROW
  • Competitive Environment Analysis, ROW

Growth Opportunity Universe

  • Growth Opportunity Summary
  • Growth Opportunity 1-Opportunities with Breast Cancer Screening Using Mobile Mammography and Mobile Ultrasound
  • Growth Opportunity 1-Opportunities with Breast Cancer Screening Using Mobile Mammography and Mobile Ultrasound (continued)
  • Growth Opportunity 2-AI Coupled with DL to Support Better Clinical Outcomes in Breast Cancer Screening
  • Growth Opportunity 2-AI Coupled with DL to Support Better Clinical Outcomes in Breast Cancer Screening (continued)
  • Growth Opportunity 3-Utilizing CAD Triage (CADt) to Reduce Human Error and Increase Efficiency in Breast Imaging
  • Growth Opportunity 3-Utilizing CAD Triage (CADt) to Reduce Human Error and Increase Efficiency in Breast Imaging (continued)
  • Growth Opportunity 4-Partnerships with OEMs Providing Breast Screening Systems to Gain a Wider Customer Base
  • Growth Opportunity 4-Partnerships with OEMs Providing Breast Screening Systems to Gain a Wider Customer Base (continued)
  • Growth Opportunity 5-Increase in Use of CAD in APAC to Bolster Clinical Adoption in the Region
  • Growth Opportunity 5-Increase in Use of CAD in APAC to Bolster Clinical Adoption in the Region (continued)

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • Legal Disclaimer